Evidence map›Paper›PMID 23689030›Full record

ArticleJournal of neuroimmunology2013

The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells.

Toan A Phan, Andrew W Taylor

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroimmunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Neuropeptide Y as a Neuro-Immune Checkpoint in Cancer.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. The Role of Neuropeptides in Pathogenesis of Dry Dye.Journal of clinical medicine · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Toan A PhanDepartment of Ophthalmology, Boston University School of Medicine, Boston, MA, USA.
Andrew W Taylor
Boston University · US

Funding

Neuroimmunomodulation within the eyeR01EY010752 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI TAYLOR, ANDREW W · 2002 to 2011
$4.2M
NEI NIH HHS EY01752NEI NIH HHS R01 EY010752
6 · The paper itself

Abstract

Within the immunosuppressive ocular microenvironment, there are constitutively present the immunomodulating neuropeptides alpha-melanocyte stimulating hormone (α-MSH) and neuropeptide Y (NPY) that promote suppressor functionality in macrophages. In this study, we examined the possibility that α-MSH and NPY modulate phagocytic activity in macrophages. The macrophages treated with α-MSH and NPY were significantly suppressed in their capacity to phagocytize unopsonized Escherichia coli and Staphylococcus aureus bioparticles, but not antibody-opsonized bioparticles. The neuropeptides significantly suppressed phagolysosome activation, and the FcR-associated generation of reactive oxidative species as well. This suppression corresponds to neuropeptide modulation of macrophage functionality within the ocular microenvironment to suppress the activation of immunogenic inflammation.

Indexed as

alpha-MSHAnimalsCell Line, TumorEscherichia coliEscherichia coli InfectionsLeukemia, Monocytic, AcuteMacrophagesMiceNeuroimmunomodulationNeuropeptide YPhagocytosisPhagosomesReactive Oxygen SpeciesRetinaStaphylococcal InfectionsStaphylococcus aureusalpha-MSHNeuropeptide YReactive Oxygen Species

Identifiers

PMID23689030
PMCPMC3679250
OpenAlexW2068761652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.